You are here

Philips to buy cardiac devices firm Spectranetics for US$1.7b

Friday, June 30, 2017 - 05:50


ROYAL Philips NV's US$1.7 billion deal to buy Spectranetics Corp, a US maker of devices to treat cardiac disease, shows the Dutch company is moving more aggressively to bolster its growing health-care business.

Philips will offer US$38.50 a share in cash for the Colorado

Market voices on:

Pair your daily business read with the perfect cup of espresso.

Subscribe to The Business Times today to receive your very own Nespresso Inissia coffee machine worth $188.

Find out more at

Powered by GET.comGetCom